In a murine K-RAS-driven lung cancer model designed to reversibly inhibit c-MYC, c-MYC inhibition not only induced regression of incipient and established lung tumors, it also exerted profound effects on normal regenerating tissues, as might be anticipated. The gene discussed is MYC; the disease is lung cancer.